Methods: Blood samples were collected from 5 pediatric patients [13±6 (mean±SD) months, 17±2 LVEF%] with HF before and at 4 hrs, 1, 3, 7, 14 and 30 days after VAD implant. C-miRNA profile at VAD implant and after 30 days was determined by NGS. Modified c-miRNA were validated by qRT-PCR and assessed in blood samples collected during time-course after VAD implant. Putative miRNA targets were selected using miRWalk database. Results: After NGS, a total of 169 c-miRNAs were detected in serum samples of HF pediatric patients. N=13 c-miRNAs were simultaneously modulated at 30 days after VAD implant compared to pre-VAD (Table 1). Among them, only 6 cmiRNAs were confirmed by qRT-PCR (Fig. 1A). Putative targets of selected cmiRNAs seem to be involved with a synergistic effect in the hemostatic process(Fig. 1B).

Circulating microRNA profiling in serum of pediatric patients with heart failure submitted to VAD implant

C Caselli;M G Trivella;L Pitto;M Cabiati;S Del Ry;M Rizzo;R D'Aurizio
2018

Abstract

Methods: Blood samples were collected from 5 pediatric patients [13±6 (mean±SD) months, 17±2 LVEF%] with HF before and at 4 hrs, 1, 3, 7, 14 and 30 days after VAD implant. C-miRNA profile at VAD implant and after 30 days was determined by NGS. Modified c-miRNA were validated by qRT-PCR and assessed in blood samples collected during time-course after VAD implant. Putative miRNA targets were selected using miRWalk database. Results: After NGS, a total of 169 c-miRNAs were detected in serum samples of HF pediatric patients. N=13 c-miRNAs were simultaneously modulated at 30 days after VAD implant compared to pre-VAD (Table 1). Among them, only 6 cmiRNAs were confirmed by qRT-PCR (Fig. 1A). Putative targets of selected cmiRNAs seem to be involved with a synergistic effect in the hemostatic process(Fig. 1B).
2018
Istituto di Fisiologia Clinica - IFC
Istituto di informatica e telematica - IIT
bioinformatica
File in questo prodotto:
File Dimensione Formato  
prod_396177-doc_137162.pdf

solo utenti autorizzati

Descrizione: Circulating microRNA profiling in serum of pediatric patients with heart failure submitted to VAD implant
Tipologia: Versione Editoriale (PDF)
Dimensione 1.04 MB
Formato Adobe PDF
1.04 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/353367
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact